Trial data could pave way for FDA OK of PillCam Colon this year

05/23/2013 | Bloomberg Businessweek

Given Imaging said its PillCam Colon, a pill-sized camera designed to detect colon cancer, proved to be as effective as a colonoscopy in helping doctors identify precancerous tumors in a clinical study. The results could help pave the way for the Israeli company to obtain FDA approval for the device this year, CEO Homi Shamir said.

View Full Article in:

Bloomberg Businessweek

Published in Briefs:

SmartBrief Job Listings for Health Care